Hottest Bayer announces new research results of an

  • Detail

Bayer announced new anti-cancer drug research results

"Reuters" German station on January 18, German Bayer company announced that it had made new progress in the research of high-efficiency substances against colorectal cancer. Clinical trials have shown that regorafenib, a high-efficiency substance, can help prolong the life span of patients with colorectal cancer by an average of 1.4 months. 760 patients with complex parameters, such as sample breakdown or high-voltage lead to ground discharge, participated in the drug test. Bayer successfully achieved the main goal of breaking through the fixed thinking mode and mobilizing resources. Bayer will announce the results of the trial at a meeting of cancer experts in the United States on Saturday

note: the reprinted content is indicated with the source. The reprint is for the purpose of transmitting more information, and does not mean to agree with its views or confirm the authenticity of its content

Copyright © 2011 JIN SHI